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ABSTRACT
Objectives: To explore the feasibility and acceptability of
self-sampling for oropharyngeal and rectal specimens to
screen for sexually transmitted infections (STIs) among
men who have sex with men (MSM). Participant’s
willingness to self-sample at home was also explored.
Methods: Participants of a study to evaluate the
sensitivity and specificity of self versus nurse taken
oropharyngeal and rectal specimens were surveyed to
assess the feasibility and acceptability of self-sampling
using specimen collection methods (gargle, OraSure
mouth pad to collect oropharyngeal specimens and
APTIMA unisex swabs to collect rectal and pharyngeal
specimens). Acceptability was measured using a five-
point Likert-type response scale (for example, 1 =
strongly disagree; 5 = strongly agree). Open-ended
questions explored participants’ experiences of self-
sampling.
Results: Of 334 eligible MSM, 301 (90%) participated in
the study. Altogether, 301 participants self-sampled using
gargle and rectal and pharyngeal swabs and 288 using
mouth pad. Complete questionnaire data from 274
participants showed that feasibility and acceptability of
self-sampling using gargle and mouth pad was higher
(92%) than pharyngeal swabs (76%). Rectal swabs were
acceptable to 82% participants. Despite some discomfort
and difficulty in using swabs, 76% were willing to use all
four methods for self-sampling in the future. Home
sampling was acceptable (84%) as it was perceived to be
less intrusive and more convenient than a clinic visit and
likely to reduce genitourinary medicine (GUM) waiting
time.
Conclusions: Self-sampling for rectal and oropharyngeal
specimens is feasible and acceptable to MSM. Self-
sampling can be offered as an alternative to clinic-based
testing and has the potential to improve choice, access
and uptake of screening for STIs.
Prevention of onward transmission of sexually
transmitted infections (STIs) is a vital public
health strategy. Early diagnosis and treatment of
STIs, particularly among at-risk groups (men who
have sex with men (MSM), sex workers), and
timely access to sexual health services are critical
components of this strategy. Recent data from the
UK report the increase in the rates of bacterial STIs
like Neisseria gonorrhoea, Chlamydia trachomatis and
syphilis among MSM.1 2 In a recent outbreak of
Lymphogranuloma venereum, almost 99% of the
diagnosed cases were among MSM.3 High rates of
STIs are also reported among MSM with HIV.4
This increase in the prevalence of STIs is a concern
as STIs can enhance transmission of HIV.5 6 Recent
epidemiological data show high prevalence of
asymptomatic pharyngeal N gonorrhoea and rectal
C trachomatis and N gonorrhoea,7 8 and high rates of
partner acquisition and unprotected sex among
MSM,7 9 emphasising the need to encourage and
improve access to regular screening among MSM.
There is a high level of unmet need for sexual
health services due to failure of genitourinary
medicine (GUM) clinics to cope with the recent
increase in demand for these services10 and GUM
waiting times of up to 28 days have been
reported.11 Given the correlation between the
average duration and transmission of STIs,12 delay
in diagnosis and treatment of STIs can enhance
their onward transmission. Thus, novel strategies
to improve access to sexual health services need to
be devised.13
Compared to the older culture methods,
nucleic acid amplification tests (NAATs) have
greater sensitivity for detecting C trachomatis and
N gonorrhoea.6 14 NAATs can be used to detect
organisms in non-invasive specimens like urine and
self-collected swabs15 and, thus, can create an
opportunity to offer self-sampling for specimens
to screen for STIs. Several studies conducted
predominantly among heterosexual populations
in the UK have shown the feasibility of screening
for genital chlamydial infections using home-
collected urine specimens from men and urine
specimens or self-collected vulvo-vaginal swabs
from women.16–18 Given the increase in pharyngeal
and rectal infections among MSM, the feasibility
and acceptability of self-sampling for specimens
from these non-genital sites needs exploration.
Recent studies conducted in the USA among MSM
have reported the feasibility of using illustrated
instructions to obtain self-collected rectal swabs.19
To date, no such studies of self-sampling with
rectal swabs have been conducted in the UK and
no studies anywhere have explored the feasibility
of self-sampling for pharyngeal specimen using
swabs.
Patients’ preferences and perspectives affect the
outreach and uptake of novel healthcare strategies;
thus, there is a need to explore the acceptability of
self-sampling for rectal and oropharyngeal speci-
mens and the willingness to self-sample in non-
clinical settings. This study aims to assess the
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feasibility, acceptability and experiences of MSM who self-
sampled for oropharyngeal and rectal specimens in the clinic
using various self-administered methods and illustrated infor-
mation leaflets. Participant’s willingness to self-sample at home
was also explored.
METHODS
Study design
This study was part of a larger study to evaluate the sensitivity
and specificity of self-collected rectal and oropharyngeal speci-
mens tested using Gen-Probe APTIMA Combo 2 assay (Gen-
Probe, San Diego, California, USA) to detect C trachomatis and
N gonorrhoea compared with nurse-taken specimens tested using
conventional clinic methods. Details of this study, including
sample size calculations, are described elsewhere.20
Study setting and population
MSM attending the Brighton GUM clinic for a routine STIs
screen aged 18 years and above were eligible to participate in the
study.
Study procedures
Written informed consent was obtained by a research nurse.
First, the nurse collected urethral, pharyngeal and rectal
specimens from all the study participants, as per the standard
clinical guidelines, followed by additional rectal and pharyngeal
specimens using the Gen-Probe APTIMA Unisex Swabs (Gen-
Probe, San Diego, California, USA). Participants were then
provided information leaflets containing photographs and
instructions for self-sampling using these sampling materials.
These information leaflets were developed during the formative
phase of this project and were based on focus group discussions
with MSM. Oropharyngeal specimens were collected using
gargle, mouth pad and pharyngeal swab, and rectal specimen
was collected using a rectal swab (table 1). Specimen collection
using a mouth pad was subsequently discontinued halfway in
the study as a planned interim analysis showed the poor
sensitivity of this sampling method.
After self-sampling, participants completed a piloted ques-
tionnaire on socio-demographic factors (age, education, ethni-
city, sexuality and employment) and frequency of STIs testing
in the past year. Feasibility and acceptability of self-sampling
using each specimen collection method was assessed using an
eight-item scale: participants’ experiences of self-sampling for
rectal and oropharyngeal specimens with the help of informa-
tion leaflets indicating the feasibility of self-sampling and
attitude towards future use of these methods for self-sampling,
and the willingness to use these methods at home indicating
acceptability of self-sampling. An additional item (preference for
nurse-taken swabs) was included in the scales of the rectal and
pharyngeal swabs. Half of these items were reverse-phrased to
reduce response bias. Participants rated each item on a five-
point Likert-type response scale: 1 = strongly disagree, 2 =
disagree, 3 = not sure, 4 = agree and 5 = strongly agree.
Finally, open-ended questions like ‘‘do you have suggestions for
improvement (for each sampling method)’’ and ‘‘please provide
additional comments’’ were included in the questionnaire.
Outcome measures and data analysis
The main study outcome was overall scale scores for feasibility
and acceptability of self-sampling for specimens from the
rectum and pharynx. Overall scale scores for each method were
derived by adding the scores of all the individual items and
dividing it by the total number of scale items. This score was
then collapsed into categories with scores ,2.5 indicating
‘‘unacceptability’’, 2.5 to ,3.5 indicating ‘‘uncertainty’’ and
>3.5 indicating ‘‘acceptability’’. Feasibility of self-sampling
defined as the ability to self-sample with the help of
instructions was measured through scores of individual item
(1–6 and 9) and acceptability was defined as the willingness of
participants to use these methods in the future and measured
through individual items 7–8. Questionnaire data entry and
cleaning was done using SPSS V.14 (SPSS, Illinois, USA).
Reverse-phrased items in the acceptability scales were reverse-
scored. Corrected item-total correlations and reliability
(Cronbach’s alpha) for each scale were computed. Medians
and interquartile ranges were calculated for individual items on
the scales. Bivariate analysis using x2 test explored the
association of overall scale scores for each specimen collection
method, indicating feasibility and acceptability of self-sampling
with socio-demographic factors (age, education, sexuality and
employment) and number of times tested for STIs in the last
year. Continuous variables such as age and number of times
screened for STIs in past year were collapsed into categorical
variables. For this analysis, overall scale scores of ,3.5 were
categorised as ‘‘unacceptable’’ and scores >3.5 were categorised
as ‘‘acceptable’’.
RESULTS
Of the 334 eligible participants, 301 (90%) were recruited during
the 20-month period from October 2005 to May 2007.
Altogether, 10% declined to participate due to concerns of
being unable to understand the information leaflets, feeling
uncomfortable with self-sampling or concerns about DNA
testing (performed to determine the accuracy of the specimens
collected). All the 301 participants successfully self-sampled for
oropharyngeal specimens using gargle and pharyngeal swab and
rectal swab. Mouth pads were successfully collected by 228
participants prior to their discontinuation. Complete question-
naire data available from 274 participants were analysed.
Median age of the study participants was 34 years (table 2).
The majority were Caucasian, employed full-time, had higher
education and 75% had previously tested for STIs.
Reliability of the acceptability scales
The corrected item-total correlations for each scale were all
above 0.3 indicating a good range of correlations between each
item and the total scale score. Item reduction did not take place
as alpha values were reduced below the overall scale alpha
indicating that all the items in the scale were positively
contributing to the overall reliability of the scale. Cronbach
alpha scores for each scale indicated that the scales devised to
Table 1 Materials used for self-sampling for rectal and oropharyngeal
specimens
Sampling materials Site of specimen collection
2 Gen-Probe APTIMA Unisex Swabs
(Gen-Probe, San Diego, California,
USA)
Pharyngeal specimen and rectal specimen
1 OraSure oral specimen collection
device (OraSure Technologies,
Philadelphia, USA)
Oral (mouth) specimen
1 container with saline water to gargle
(Sterilin, Caerphilly, UK); 1 Gen-Probe
APTIMA urine collection kit (pipette
and a specimen transport tube)
Oropharyngeal specimen (using the saline
water participants gargled for 45 s and spit
back into the container. They then transferred
this water using a pipette in the specimen
transport tube).
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measure feasibility and acceptability of self-sampling were
reliable (table 3).
Feasibility of using oropharyngeal specimen collection methods
Of the three oropharyngeal specimen collection methods, the
overall scores were the highest for mouth pad (96%), followed
by gargle (92%) and the pharyngeal swab (76%) (table 3). While
2.2% participants reported throat swabs to be unacceptable
almost 22% reported being unsure of their acceptability. The
individual item scores (1–6) indicate that the majority of the
participants found specimen collection using mouth pad and
gargle to be feasible. However, the collection of a pharyngeal
swab was reported to be difficult (24%) and uncomfortable
(32.5%), and 37% participants expressed preference for nurse-
taken pharyngeal swab, indicating that not all participants
found self-sampling with throat swab to be feasible. Open-
ended responses indicated the following difficulties experienced
by participants while self-sampling with the pharyngeal swab:
unclear illustration of the throat area to be swabbed, experien-
cing a gagging sensation and difficulty in avoiding the tongue
while swabbing. Participants also reported that the time they
were required to gargle (45 seconds) was too long and some
expressed the need for a bigger pot to spit the gargle in.
Feasibility of using rectal specimen collection method
Overall scores indicate that 82% participants were able to self-
sample using rectal swabs and were willing to use them in the
future, whereas 14% were unsure and 4% found them
unacceptable (table 3). As in the case of throat swabs,
preference for nurse-taken rectal specimen was reported (26%)
and individual item scores indicate that some participants found
self-sampling for a rectal specimen to be difficult (19%) and
uncomfortable (30.5%). Open-ended responses indicated that
participants experienced the following difficulties in self-
sampling with a rectal swab: difficulty inserting the swab in
the anus, discomfort because of dryness, fear of causing bleeding
while inserting the swab, not understanding the depth to which
the swab needed to be inserted in the rectum. Participants
suggested having a mark on the rectal swab to indicate the
depth to which it needs to be inserted and providing thicker
swabs.
Acceptability of self-sampling and home-sampling
Although participants reported some discomfort in using the
swabs, the majority of the participants expressed their will-
ingness to use all the methods for self-sampling in the future
Table 2 Profile of the study participants (n = 274)*
Factors %
Median age, years (IQR) 34 (29–41)
Age distribution
18–30 years 35.4
31–40 years 38.2
.40 years 26.4
Sexuality
Homosexual 95.9
Bisexual 4.1
Ethnicity
Caucasian 94.8
Education
No formal education 5.2
A/O levels 32.5
Higher education (degree/higher degree) 62.3
Employment
Unemployed 4.8
Full-time 63.8
Part-time/self-employed 15.5
Other 15.9
Times tested for STIs in the last year (n = 270)
Range (tested for STIs) 0–12
0 25.3
1–2 53.2
>3 21.5
*n = 274 unless otherwise specified. IQR, inter-quartile range; STI, sexually
transmitted infections.
Table 3 Reliability of scales, overall feasibility and acceptability scores of each specimen collection method and median with inter-quartile range (IQR)
of individual scale items
Overall Cronbach alpha Mouth pad (n = 201) Gargle (n = 274) Pharyngeal swab (n = 274) Rectal swab (n = 268)
Overall feasibility and
acceptability scores 0.77% (95% CI) 0.86% (95% CI) 0.85% (95% CI) 0.88% (95% CI)
Unacceptable 0 (0 to 1.9) 0.4 (0.6 to 2.0) 2.2 (1.0 to 4.7) 4.0 (2.3 to 7.2)
Not sure 4.0 (2.0 to 7.7) 7.7 (5.0 to 11.4) 21.7 (17.0 to 27.0) 14.2 (10.5 to 18.9)
Acceptable 96.0 (92.0 to 97.9) 92.0 (88.6 to 94.6) 76.0 (70.7 to 80.8) 81.7 (76.7 to 85.9)
Individual item scores
(Likert scale of 1–5)
Median (IQR) Median (IQR) Median (IQR) Median (IQR)
1 Found collection of the specimen
easy
5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 4.0 (3.0 to 5.0) 4.0 (3.0 to 5.0)
2 Instructions easy 4.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0)
3 (Uncomfortable)* to self-collect the
specimen
4.0 (4.0 to 5.0) 4.0 (4.0 to 5.0) 4.0 (2.0 to 4.0) 4.0 (2.0 to 4.0)
4 (Difficult)* to self-collect the
specimen
5.0 (4.0 to 5.0) 4.5 (4.0 to 5.0) 4.0 (3.0–4.0) 4.0 (3.0–5.0)
5 Instructions (difficult)* to understand 5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0)
6 Confidence about specimen collected
as instructed
4.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 4.0 (4.0 to 5.0) 4.0 (4.0 to 5.0)
7 (Not)* use the method again 5.0 (4.0 to 5.0) 5.0 (4.0 to .0) 4.0 (4.0 to 5.0) 4.0 (4.0 to 5.0)
8 Happy to use the method at home 5.0 (4.0 to 5.0) 5.0 (4.0 to 5.0) 4.0 (4.0 to 5.0) 4.0 (4.0 to 5.0)
9 (Prefer)* collection of the specimen
by nurse
NA NA 3.0 (2.0 to 4.0) 4.0 (2.0 to 4.0)
*All the items included in the () were reverse coded so their scores reflect degree of disagreement with those statements, with higher scores indicating high levels of acceptability.
NA, not applicable.
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(table 3): ‘‘I found the swabs uncomfortable but then it is quite
easy to do’’; ‘‘simple to use, not very comfortable but is no
different to visiting the clinic’’. Altogether, 95% of participants
agreed to use mouth pad and gargle at home and four of five
participants expressed willingness to use swabs for rectal and
pharyngeal specimen collection at home . The prospect of being
able to use specimen collection methods at home and its likely
impact on clinic waiting times appealed to the participants: ‘‘a
lot of people would feel more at ease to use it at home’’, ‘‘time
saving due to the lack of need to wait for an appointment in the
clinic’’, ‘‘less worrying than a clinic visit’’. Approximately 1%
expressed concerns about losing the opportunity to interact
with clinic staff, the possibility of error in collecting the sample
or feeling unconfident about self-sampling: ‘‘don’t think I
would have taken a deep (throat) swab’’, ‘‘I trust clinicians lot
more than I trust my unqualified self’’.
Factors affecting acceptability of specimen collection methods
for self-sampling
Sociodemographic variables (age, education, sexuality and
employment status) and number of times tested for STIs in
last year (categories as reported in table 2) were not significantly
associated with the feasibility and acceptability of any of these
specimen collection methods for self-sampling. Open-ended
responses from some participants indicated that prior experi-
ence of STIs testing in the clinic enabled them to self-sample for
rectal swab but this difference was not statistically significant
(p = 2.81).
DISCUSSION
Self-sampling in non-clinical settings for specimens to screen for
STIs can have a vital public health impact. It may help
overcome barriers to clinic-based testing like embarrassment
and stigma and potentially improve access to sexual health
services. Prior to offering self-sampling as an alternative to
clinic-based testing and/or for STIs screening at population
level, feasibility and acceptability to self-sample for specimens
to screen for STIs need to be understood. Our study findings
indicate that self-sampling for oropharyngeal and rectal speci-
mens is feasible and acceptable to MSM in the UK.
This is the first study to report the feasibility and
acceptability of self-sampling for pharyngeal specimens using
swabs. Participants expressed greater preference for gargle and
mouth pad compared with the pharyngeal swabs. High
acceptability of gargle is similar to that of the oral-throat
rinses reported in other studies.21 However, pharyngeal swabs
have better sensitivity compared with oral rinses for detection
of C trachomatis and N gonorrhoea.21 Similar to the findings
from other studies,19 participants in our study found self-
sampling for the rectal specimen to be feasible and acceptable.
No significant difference was observed in the sensitivity or
specificity between the clinician-taken and the patient-taken
swabs screened using Gen-Probe APTIMA Combo 2 assay for
rectal N gonorrhoea and C trachomatis and pharyngeal GC,20
indicating that these methods can be offered to screen for STIs
to MSM willing to self-sample.
Ease and convenience of using these methods at home and the
lack of need to wait for a clinic appointment appeared to
assume significance over the discomfort experienced in self-
sampling. Although 76% participants reported self-sampling
with all four methods to be feasible and acceptable the
remaining 24% were unsure or did not prefer self-sampling.
Some expressed concerns about lack of interaction with
clinicians. Thus patients should be offered a choice between
home self-sampling and regular clinic testing for STIs.
Participants in our study expressed the need for more
illustrations to be included in the information leaflets.
Another study has reported success with self-sampling for
rectal specimens with the help of illustrated instructions,19
emphasising that illustrations are necessary to make the
information leaflets user-friendly. Participants also provided
many suggestions to improve the written instructions, indicat-
ing the significance of integrating users’ perspectives in
developing such materials.
Studies conducted among women have reported the associa-
tion between ethnicity and acceptability of self-sampling.22 23
We did not explore the association of ethnicity and acceptability
because our study population was a relatively homogenous
group—that is, mainly Caucasian—indicating that the accept-
ability of these methods in other ethnic groups needs further
exploration.
Our study was clinic-based and therefore has limited
generalisability to MSM in community settings. Some MSM
did not participate in our study because of concerns about self-
sampling, although the proportion that declined was small
(10%). If analysis was conducted assuming worst case
scenario—that is, non-participants to have reported all the
self-sampling methods to be unacceptable (see supplementary
table A)—65% feasibility and acceptability of self-sampling
would still have been achieved.
Studies have reported the acceptability of the internet to
order self-sampling kits to screen for STIs,24 and home self-
sampling for bacterial infections increased screening for
STIs25 26 and improved screening in asymptomatic high-risk
women.24 25 Home self-sampling can also be used for contact
tracing27—that is, partners of MSM diagnosed positive and
reluctant to access GUM services can be offered home
sampling and encouraged to screen and access care. Further
studies to evaluate the cost-effectiveness of home self-
sampling as an alternative model to screen for bacterial STIs
among MSM are essential to understand the policy and public
health implications of such interventions and are being
undertaken as the next stage of this research study. Studies
should also explore the effect of home self-sampling kits on
screening and treatment of partners.
Key messages
c High prevalence of asymptomatic sexually transmitted
infections (STIs), unprotected sex among men who have sex
with men (MSM) and delays in access to sexual health
services in the UK can contribute to onward transmission of
STIs.
c Novel strategies are needed to improve access and promote
early diagnosis and treatment of STIs.
c Nucleic acid amplification techniques have high sensitivity and
enable self-sampling using non-invasive sampling methods like
urine and swabs to screen for STIs in non-clinical settings.
c Self-sampling for oropharyngeal and rectal specimens using
swabs, mouth pad and gargle is feasible and acceptable to
MSM attending genitourinary medicine services. The majority
of the participants were willing to use these methods at home.
c Home self-sampling for specimens can provide an alternative
to clinic-based testing for STIs and has the potential to
improve access and frequency of STIs screening.
Behaviour
Sex Transm Infect 2009;85:60–64. doi:10.1136/sti.2008.032193 63
 on 2 June 2009 sti.bmj.comDownloaded from 
In conclusion, our study findings indicate that self-sampling
for oropharyngeal and rectal specimens using illustrated
information leaflets is feasible and acceptable to MSM. Self-
sampling can provide an alternative to clinic-based testing for
STIs, especially among asymptomatic and at-risk groups willing
to self-sample, and has the potential to improve access and
reduce intervals between STIs screenings.
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